These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31540818)

  • 1. High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study.
    Berends J; Tieleman AA; Horlings CGC; Smulders FHP; Voermans NC; van Engelen BGM; Raaphorst J
    Neuromuscul Disord; 2019 Oct; 29(10):758-765. PubMed ID: 31540818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
    Wenninger S; Stahl K; Montagnese F; Schoser B
    Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body composition analysis in patients with myotonic dystrophy types 1 and 2.
    Peric S; Bozovic I; Nisic T; Banovic M; Vujnic M; Svabic T; Pesovic J; Brankovic M; Basta I; Jankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
    Neurol Sci; 2019 May; 40(5):1035-1040. PubMed ID: 30790082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires.
    Romigi A; Albanese M; Placidi F; Izzi F; Liguori C; Marciani MG; Mercuri NB; Terracciano C; Vitrani G; Petrucci A; Di Gioia B; Massa R
    Eur J Neurol; 2014 Jun; 21(6):929-34. PubMed ID: 23837695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
    DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
    J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.
    Hilbert JE; Barohn RJ; Clemens PR; Luebbe EA; Martens WB; McDermott MP; Parkhill AL; Tawil R; Thornton CA; Moxley RT;
    Neurology; 2017 Sep; 89(13):1348-1354. PubMed ID: 28855409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
    Suominen T; Bachinski LL; Auvinen S; Hackman P; Baggerly KA; Angelini C; Peltonen L; Krahe R; Udd B
    Eur J Hum Genet; 2011 Jul; 19(7):776-82. PubMed ID: 21364698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
    Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes.
    Sansone VA; Brigonzi E; Schoser B; Villani S; Gaeta M; De Ambroggi G; Bandera F; De Ambroggi L; Meola G
    Int J Cardiol; 2013 Sep; 168(2):1147-53. PubMed ID: 23266299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Falls and stumbles in myotonic dystrophy.
    Wiles CM; Busse ME; Sampson CM; Rogers MT; Fenton-May J; van Deursen R
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):393-6. PubMed ID: 16199443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in adult myotonic dystrophies: a longitudinal study.
    Sansone V; Gandossini S; Cotelli M; Calabria M; Zanetti O; Meola G
    Neurol Sci; 2007 Mar; 28(1):9-15. PubMed ID: 17385090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2.
    Tieleman AA; Knoop H; van de Logt AE; Bleijenberg G; van Engelen BG; Overeem S
    J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):963-7. PubMed ID: 20798200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal involvement is frequent in Myotonic Dystrophy type 2.
    Tieleman AA; van Vliet J; Jansen JB; van der Kooi AJ; Borm GF; van Engelen BG
    Neuromuscul Disord; 2008 Aug; 18(8):646-9. PubMed ID: 18602828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of temporal and stride characteristics in myotonic dystrophies type 1 and 2 during dual-task walking.
    Radovanović S; Perić S; Savić-Pavićević D; Dobričić V; Pešović J; Kostić V; Rakočević-Stojanović V
    Gait Posture; 2016 Feb; 44():194-9. PubMed ID: 27004657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Happened with Muscle Force, Dynamic Stability And Falls? A 10-Year Longitudinal Follow-Up in Adults with Myotonic Dystrophy Type 1.
    Hammarén E; Kollén L
    J Neuromuscul Dis; 2021; 8(6):1007-1016. PubMed ID: 34151851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
    Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.